Siranomics begins phase-I trial of siRNA drug candidate STP707 to treat tumours
The phase-I clinical trial, a multi-centre, open-label, dose-escalation and dose-expansion study, will evaluate the safety,…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.